Is Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) compatible with diphtheria-pertussis-tetanus vaccine in young infants?
Scheifele
D
D
Vaccine Evaluation Center, B.C.'s Children's Hospital, University of British Columbia, Vancouver, Canada.
Bjornson
G
G
Guasparini
R
R
Meekison
W
W
D000917:Antibody Formation; D001425:Bacterial Outer Membrane Proteins / Q000008:administration & dosage* / Q000276:immunology*; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage* / Q000276:immunology; D018073:Haemophilus Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage* / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage* / Q000276:immunology*
D001425:Bacterial Outer Membrane Proteins; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D018073:Haemophilus Vaccines; C061964:Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine; D011055:Poliovirus Vaccine, Oral; D011135:Polysaccharides, Bacterial